Membership

Join or Renew

ISCT Membership to Meet Your Needs

ISCT members are the core of our Society. With member representation at every step of the translational pathway, ISCT serves to support your unique needs as we advance the CGT field together. ISCT offers tailored membership categories for IndividualsLabs, and Industry Companies – Find the membership best suited for you.

Member Benefits

Working with regulatory and scientific experts from around the world, ISCT addresses challenges in evolving global regulatory environments, sets global scientific standards, and ensures the highest ethical principles are upheld in a rapidly changing field.

Showcase your innovations in the Official Journal of ISCT, moving science forward by forecasting key topics and building consensus for cell and gene therapy in a global, translational community. With a proven impact factor of 4.218, Cytotherapy adheres to the highest scientific standards and curates the advancements that shape our field.

ISCT members access significantly reduced rates for Annual and Regional Meetings, and other ISCT events and programs throughout the year.

Through a global mentoring program, ongoing training and education resources, and networking opportunities via ISCT Committees and events, ISCT is committed to providing emerging leaders in cell and gene therapy with the resources they need to succeed in the field.

ISCT Awards honor scientific excellence and contributions to the field of cell and gene therapy. ISCT offers a wide variety of awards to members, including the Career Achievement Award, Le Prix Luc Sensebé in Innovation and Leadership, the Darwin J. Prockop Mentoring Award, as well as Annual Meeting Awards and Regional Awards.

Connect and collaborate with a global community of over 2,400 cell and gene therapy professionals, including the most influential thought leaders in the CGT field today.

Through relationships with more than 40 partner organizations, ISCT develops sector-wide consensus on issues at the forefront of the cell and gene therapy field, including unproven cellular therapies and commercial cell banking services, Google’s advertising policies, and regulatory hurdles impacting the advancement of therapies for patients. 

Advancing Global Cell Therapy Since 1992

ISCT members represent all key areas of the clinical translation pipeline. Join the global community advancing the development and delivery of cell and gene therapies for the benefit of patients worldwide.

Translational Research

Key ISCT Stakeholders: 

  • Academics
  • Scientists
  • Enablers
  • Researcher-Clinicians
  • Intellectual Property

Preclinical Development

Key ISCT Stakeholders: 

  • Academics
  • Regulators
  • CDMOs, CROs
  • GMP Laboratories
  • Enablers
  • Manufacturing
  • Intellectual Property

Clinical (Ph I, II, III)

Key ISCT Stakeholders: 

  • Clinicians
  • Regulators
  • CDMOs, CROs, IP
  • Advanced Practice Professionals
  • Principal Investigators
  • Enablers
  • Investors
  • Manufacturing

Commercialization

Key ISCT Stakeholders: 

  • Biotech
  • Pharma
  • SMEs
  • Investors
  • Business Development

2410

Members and growing!